Update: Diagnosis and Treatment of Muscle-Invasive and Metastatic Bladder Cancer in 2014 - European Medical Journal

Update: Diagnosis and Treatment of Muscle-Invasive and Metastatic Bladder Cancer in 2014

Urology
Download PDF
Authors:
*Johannes Br√ľndl, Philipp J. Spachmann, Maximilian Burger
Disclosure:

No potential conflict of interest.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Abstract

Bladder cancer (BC) is the ninth most commonly diagnosed malignant tumour in the world, with an incidence of about 356,000 and a mortality of about 145,000 per year in both non-muscle-invasive and muscle-invasive BC. Although a high percentage of urothelial cancers of the bladder are staged as non- muscle-invasive, muscle invasion can already be found in about 30% of all patients at the time of initial diagnosis. The intention of the following article is to give an overview of the diagnosis and treatment of muscle-invasive and metastatic BC according to the latest update of the EAU (European Association of Urology) guidelines.

Please view the full content in the pdf above.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now